Technical and imaging outcomes from the UK registry of prostate artery embolization (UK-ROPE) study: Focusing on predictors of clinical success
Technical and imaging outcomes from the UK registry of prostate artery embolization (UK-ROPE) study: Focusing on predictors of clinical success
INTRODUCTION: The UK Registry of Prostate Artery Embolization (UK-ROPE) was a prospective, multicentre study comparing PAE against surgical therapies for symptomatic benign prostatic hyperplasia (BPH). A wealth of data was collected supplementary to the main study outcomes which provide a snapshot of UK PAE practice. We aimed to interpret these data in the hope of providing insight into factors which affect clinical outcome and radiation dose.
METHODS: 216 patients (mean age 66, mean IPSS 21.3) undergoing PAE at 20 British centres from July 2014 to January 2016 were prospectively followed up to 12 months with retrospective analysis of the data. Technical outcome was evaluated based on procedural and fluoroscopy times, skin dose and dose area product (DAP). Clinical outcome was evaluated through collection of Qmax, IPSS reduction and prostate volume reduction. Multiple analysis of variance (MANOVA) was used to assess the significance of various patients and procedural factors on clinical outcome and patient dose.
RESULTS: Significant predictors of technical outcome which affected patient skin dose included severity of CTA-detected atheroma (p < 0.001), the practitioner (p < 0.001) and use of protective coil embolization (p = 0.019). Predictors of clinical outcome included initial prostate size (dichotomized into groups > 80 ml and = <80 ml, d = 1, p = 0.0138), embolic agent (spherical particles < 300 nm performed best, p = 0.01) and number of arteries embolized (IPSS reduction of 32.9% in unilateral PAE versus 54.4% for bilateral PAE, p = 0.026).
CONCLUSION: We have identified several important factors which are associated with improved clinical outcome and increased patient dose which we hope will facilitate optimal patient selection and encourage improved embolization technique.
Aged, Arteries, Embolization, Therapeutic/methods, Follow-Up Studies, Humans, Male, Prospective Studies, Prostate/blood supply, Prostatic Hyperplasia/therapy, Registries, Retrospective Studies, Treatment Outcome, United Kingdom
666-676
Hacking, Nigel
fdc70f9c-e9d6-485c-a53d-e6988fa75cb0
Vigneswaran, Ganesh
4e3865ad-1a15-4a27-b810-55348e7baceb
Maclean, Drew
bf15fb9d-aa6d-4d13-8cae-ede6a3329779
Modi, Sachin
caef086a-dda5-418a-ada8-fc042e6e0b18
Dyer, Jonathan
67e4120e-4ed4-44d0-a72a-93ae3e265fcb
Harris, Mark
065415f3-96a7-443c-91b4-f75a5945f82b
Bryant, Timothy
05bd12ef-e864-450e-96f5-addcc60c173d
2 January 2019
Hacking, Nigel
fdc70f9c-e9d6-485c-a53d-e6988fa75cb0
Vigneswaran, Ganesh
4e3865ad-1a15-4a27-b810-55348e7baceb
Maclean, Drew
bf15fb9d-aa6d-4d13-8cae-ede6a3329779
Modi, Sachin
caef086a-dda5-418a-ada8-fc042e6e0b18
Dyer, Jonathan
67e4120e-4ed4-44d0-a72a-93ae3e265fcb
Harris, Mark
065415f3-96a7-443c-91b4-f75a5945f82b
Bryant, Timothy
05bd12ef-e864-450e-96f5-addcc60c173d
Hacking, Nigel, Vigneswaran, Ganesh, Maclean, Drew, Modi, Sachin, Dyer, Jonathan, Harris, Mark and Bryant, Timothy
(2019)
Technical and imaging outcomes from the UK registry of prostate artery embolization (UK-ROPE) study: Focusing on predictors of clinical success.
Cardiovascular and Interventional Radiology, 42 (5), .
(doi:10.1007/s00270-018-02156-8).
Abstract
INTRODUCTION: The UK Registry of Prostate Artery Embolization (UK-ROPE) was a prospective, multicentre study comparing PAE against surgical therapies for symptomatic benign prostatic hyperplasia (BPH). A wealth of data was collected supplementary to the main study outcomes which provide a snapshot of UK PAE practice. We aimed to interpret these data in the hope of providing insight into factors which affect clinical outcome and radiation dose.
METHODS: 216 patients (mean age 66, mean IPSS 21.3) undergoing PAE at 20 British centres from July 2014 to January 2016 were prospectively followed up to 12 months with retrospective analysis of the data. Technical outcome was evaluated based on procedural and fluoroscopy times, skin dose and dose area product (DAP). Clinical outcome was evaluated through collection of Qmax, IPSS reduction and prostate volume reduction. Multiple analysis of variance (MANOVA) was used to assess the significance of various patients and procedural factors on clinical outcome and patient dose.
RESULTS: Significant predictors of technical outcome which affected patient skin dose included severity of CTA-detected atheroma (p < 0.001), the practitioner (p < 0.001) and use of protective coil embolization (p = 0.019). Predictors of clinical outcome included initial prostate size (dichotomized into groups > 80 ml and = <80 ml, d = 1, p = 0.0138), embolic agent (spherical particles < 300 nm performed best, p = 0.01) and number of arteries embolized (IPSS reduction of 32.9% in unilateral PAE versus 54.4% for bilateral PAE, p = 0.026).
CONCLUSION: We have identified several important factors which are associated with improved clinical outcome and increased patient dose which we hope will facilitate optimal patient selection and encourage improved embolization technique.
This record has no associated files available for download.
More information
Published date: 2 January 2019
Keywords:
Aged, Arteries, Embolization, Therapeutic/methods, Follow-Up Studies, Humans, Male, Prospective Studies, Prostate/blood supply, Prostatic Hyperplasia/therapy, Registries, Retrospective Studies, Treatment Outcome, United Kingdom
Identifiers
Local EPrints ID: 448615
URI: http://eprints.soton.ac.uk/id/eprint/448615
ISSN: 0174-1551
PURE UUID: ebb3adbe-8658-4a21-8161-34024cc06d0c
Catalogue record
Date deposited: 28 Apr 2021 16:32
Last modified: 17 Mar 2024 04:06
Export record
Altmetrics
Contributors
Author:
Nigel Hacking
Author:
Drew Maclean
Author:
Sachin Modi
Author:
Jonathan Dyer
Author:
Mark Harris
Author:
Timothy Bryant
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics